59 related articles for article (PubMed ID: 7794813)
1. Phenotypic modification of human osteosarcoma cells with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
Ringbom-Anderson T; Sandberg M; Andersson G; Akerman KE
Cell Growth Differ; 1995 Apr; 6(4):457-64. PubMed ID: 7794813
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor potentiates phorbol ester-induced neuronal differentiation of human neuroblastoma cells.
Påhlman S; Johansson I; Westermark B; Nistér M
Cell Growth Differ; 1992 Nov; 3(11):783-90. PubMed ID: 1467306
[TBL] [Abstract][Full Text] [Related]
3. DNA synthesis in U-2 OS human osteosarcoma cells is independent of PDGF binding to functional cell surface receptors.
Richter MR; Graves DT
J Cell Physiol; 1988 Jun; 135(3):474-80. PubMed ID: 2840434
[TBL] [Abstract][Full Text] [Related]
4. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
Kujoth GC; Fahl WE
Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
6. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
Schönherr E; Kinsella MG; Wight TN
Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
[TBL] [Abstract][Full Text] [Related]
7. Expression of the platelet-derived growth factor 1 and 2 genes in human myeloid cell lines and monocytes.
Sariban E; Kufe D
Cancer Res; 1988 Aug; 48(16):4498-502. PubMed ID: 3165051
[TBL] [Abstract][Full Text] [Related]
8. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.
Oda Y; Wehrmann B; Radig K; Walter H; Röse I; Neumann W; Roessner A
Gen Diagn Pathol; 1995 Oct; 141(2):97-103. PubMed ID: 8548600
[TBL] [Abstract][Full Text] [Related]
9. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.
Di Paolo S; Gesualdo L; Ranieri E; Grandaliano G; Schena FP
Am J Pathol; 1996 Dec; 149(6):2095-106. PubMed ID: 8952542
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor.
Keyes LE; Moore LG; Walchak SJ; Dempsey EC
J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
12. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line.
Vassbotn FS; Ostman A; Langeland N; Holmsen H; Westermark B; Heldin CH; Nistér M
J Cell Physiol; 1994 Feb; 158(2):381-9. PubMed ID: 8106574
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
14. Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells.
Fox PL; DiCorleto PE
J Cell Physiol; 1984 Nov; 121(2):298-308. PubMed ID: 6490729
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma.
Sulzbacher I; Träxler M; Mosberger I; Lang S; Chott A
Mod Pathol; 2000 Jun; 13(6):632-7. PubMed ID: 10874667
[TBL] [Abstract][Full Text] [Related]
16. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
[TBL] [Abstract][Full Text] [Related]
17. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
18. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
Dorai T; Kobayashi H; Holland JF; Ohnuma T
Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
[TBL] [Abstract][Full Text] [Related]
19. IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression.
Yeh YL; Kang YM; Chaibi MS; Xie JF; Graves DT
J Immunol; 1993 Jun; 150(12):5625-32. PubMed ID: 8515080
[TBL] [Abstract][Full Text] [Related]
20. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains.
Heldin CH; Johnsson A; Wennergren S; Wernstedt C; Betsholtz C; Westermark B
Nature; 1986 Feb 6-12; 319(6053):511-4. PubMed ID: 3456080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
